Literature DB >> 32158656

Risk Indicators for Hearing Impairment in Neonates.

Megha M Panjiyar1,2, Samir K Bhargava1,2, Vinod Gite3, Neeraj R Shetty1,2, Shashikant Mhashal1,2.   

Abstract

To identify relation between prevalence of hearing impairment and risk factors at the time of birth in high risk neonates. A year-long study is performed at HBT Medical College and Dr. R. N. Cooper Municipal General Hospital, Vile Parle (west), Mumbai. The Study comprised of 478 high risk babies born between March 2016 and February 2017 and admitted in NICU of the hospital. Out of these 68 babies were either transferred to higher centre or took discharge against medical advice. A total of 410 babies completed the study. Additional 21 eligible babies died in NICU during the study. A Prospective Observational Study is used to analyse the findings of the study. Skew analysis of spread of prevalence across risk factors is used to establish higher prevalence of hearing impairment in high risk neonates. Cramer's Moment Coefficient of Skewness and Corresponding Test Statistics are used for studying the skewness. Out of 410 babies screened during the study 5 babies were diagnosed with profound SNHL. The risk factors associated with babies is plotted against frequency of babies with Profound SNHL. The plot is found to be un-uniformly distributed and shows inclination towards higher prevalence with high risk babies. Sample skewness (G1) value - 0.81 indicates moderately negative skewed sample. This means the number of babies with profound SNHL found by 3 stage screening is moderately concentrated at high risk weightage. © Association of Otolaryngologists of India 2019.

Entities:  

Keywords:  Cost effective screening; Hearing impairment; High risk neonates; Profound SNHL; Risk factors

Year:  2019        PMID: 32158656      PMCID: PMC7040106          DOI: 10.1007/s12070-019-01735-6

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  1 in total

Review 1.  Global burden of childhood hearing impairment and disease control priorities for developing countries.

Authors:  Bolajoko O Olusanya; Valerie E Newton
Journal:  Lancet       Date:  2007-04-14       Impact factor: 79.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.